BeOne Medicines AG
SWB:49BA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BeOne Medicines AG
SWB:49BA
|
CH |
|
Duro Felguera SA
MAD:MDF
|
ES |
|
T
|
Tabcorp Holdings Ltd
F:THL
|
AU |
|
DocMorris AG
F:ZRE
|
CH |
|
Zeda Ltd
F:LJ0
|
ZA |
|
P
|
Premier Miton Group PLC
OTC:PASMF
|
UK |
Wall St Price Targets
49BA Price Targets Summary
BeOne Medicines AG
According to Wall Street analysts, the average 1-year price target for 49BA is 446.98 EUR with a low forecast of 373.04 EUR and a high forecast of 576.26 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 49BA's stock price target?
Price Target
446.98
EUR
According to Wall Street analysts, the average 1-year price target for 49BA is 446.98 EUR with a low forecast of 373.04 EUR and a high forecast of 576.26 EUR.
What is the Revenue forecast for BeOne Medicines AG?
Projected CAGR
11%
Over the last 6 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for BeOne Medicines AG?
Projected CAGR
10%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 54%. The projected CAGR for the next 6 years is 10%.
What is the Operating Income forecast for BeOne Medicines AG?
Projected CAGR
33%
The compound annual growth rate for Operating Income over the next 8 years is 33%.
What is the Pre-Tax Income forecast for BeOne Medicines AG?
Projected CAGR
73%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 73%.
What is the Net Income forecast for BeOne Medicines AG?
Projected CAGR
45%
The compound annual growth rate for Net Income over the next 8 years is 45%.